<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="/css/uswds.min.css">
    <link rel="stylesheet" href="/css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="/index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="/index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="/html/titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                <a href="/html/parts/21CFR520.html">Part 520
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 520.82  Aminopropazine oral dosage forms.

Sec. 520.82a  Aminopropazine.
                            </h3>
                            <p class="depth0"><em>(a)</em> Specifications. Each tablet contains aminopropazine fumarate equivalent to 25 percent aminopropazine base.</p><p class="depth0"><em>(b)</em> Sponsor. See No. 000061 in Sec. 510.600(c) of this chapter.</p><p class="depth0"><em>(c)</em> Conditions of use in dogs and cats--(1) Amount. Administer orally at a dosage of 1 to 2 milligrams per pound of body weight, repeated every 12 hours as indicated.</p><p class="depth0"><em>(1)</em> Amount. Administer orally at a dosage of 1 to 2 milligrams per pound of body weight, repeated every 12 hours as indicated.</p><p class="depth0"><em>(2)</em> Indications for use. For reducing excessive smooth muscle contractions, such as occur in urethral spasms associated with urolithiasis.</p><p class="depth0"><em>(3)</em> Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
[79 FR 28816, May 20, 2014]


Sec. 520.82b  Aminopropazine and neomycin.</p><p class="depth0"><em>(a)</em> Specifications. Each tablet contains aminopropazine fumarate equivalent to 25 percent aminopropazine base and neomycin sulfate equivalent to 50 milligrams (mg) of neomycin base.</p><p class="depth0"><em>(b)</em> Sponsor. See No. 000061 in Sec. 510.600(c) of this chapter.</p><p class="depth0"><em>(c)</em> Conditions of use in dogs--(1) Amount. Administer orally at a dosage of 1 to 2 mg per pound of body weight, repeated every 12 hours as indicated.</p><p class="depth0"><em>(1)</em> Amount. Administer orally at a dosage of 1 to 2 mg per pound of body weight, repeated every 12 hours as indicated.</p><p class="depth0"><em>(2)</em> Indications for use. For control of bacterial diarrhea caused by organisms susceptible to neomycin and to reduce smooth muscle contractions.</p><p class="depth0"><em>(3)</em> Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
[79 FR 28816, May 20, 2014]</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
